Typically, the consultants will inform us what we already know. Ray Dalio, the founding father of Bridgewater Associates, has constructed a legendary repute in monetary circles, for taking his agency from a house enterprise in his two-bedroom condo to the worldwide hedge fund big, using over 1,500 folks and managing greater than $138 billion in whole property. However when questioned on how he did it, or how at the moment’s traders can survive the continuing pandemic disaster, his recommendation can sound downright unusual.Dalio’s recommendation for investing throughout the pandemic will be summed up simply sufficient. First, he says to diversify the portfolio. Diversification means spreading out the chance, which in flip will scale back your losses ought to one – and even a number of – investments flip south. Second, Dalio tells us to not trouble making an attempt to ‘time the market.’ Even the professionals don’t normally get this proper, and Dalio says that merely shopping for right into a inventory you want, and holding it long run, is a greater technique then making an attempt to purchase in on the proper time. The inventory market is a dangerous place to place your cash, and Dalio understands that. His techniques for mitigating that danger are age-old – and have arguably introduced him nice success. Bearing this in thoughts, we determined to take a look at Bridgewater’s current exercise for inspiration. Working three shares Dalio’s fund picked up throughout Q3 by way of TipRanks’ database, we came upon that the analyst group can also be on board, as every sports activities a “Strong Buy” consensus score.Baxter Worldwide (BAX)We’ll begin with Baxter Worldwide, a healthcare firm primarily based outdoors of Chicago. Baxter produces medical gadgets and different merchandise for the remedy of acute and continual circumstances, significantly blood, immune, and kidney ailments. The corporate markets primarily to healthcare professionals and establishments, slightly than the open market, and boasts over $11 billion in annual income.The corporate’s revenues by way of 2020 have been secure, and in-line with historic values. Baxter ended 2019 with a $Three billion quarter; that slipped to $2.72 billion 1Q20, however had risen steadily to $2.97 billion by 3Q20. The corporate pays out a modest dividend for traders, which at 24.5 cents per frequent share provides a yield of 1.3%.Dalio’s place in Baxter is a brand new one for him. His agency purchased up 124,701 shares of the inventory, a holding that’s price $9.73 million at present costs.5-star analyst Danielle Antalffy, of SVB Leerink, writes of Baxter, “[We] see BAX’s underlying fundamentals — accelerating sales growth, meaningful margin expansion — as unchanged. One of the most meaningful datapoints in this quarter was 6% peritoneal dialysis patient growth… well ahead of the mid-single-digit long-term growth outlook for the Renal business that the Street is modeling. As the COVID pressures begin to lift, visibility into the long-term growth drivers should improve, and we would expect the shares to move meaningfully higher.”In keeping with her bullish feedback, Antalffy charges BAX shares an Outperform (i.e. Purchase), and her $105 worth goal implies a 34% one-year upside potential. (To look at Antalffy’s monitor file, click on right here)Total, the analyst consensus score on Baxter is a Robust Purchase, primarily based on 12 critiques that embrace 11 Buys in opposition to only a single Maintain. The inventory is promoting for $78, and its $95 common worth goal counsel it has room for ~22% upside development in 2021. (See BAX inventory evaluation on TipRanks)CVS Well being Company (CVS)The following inventory is one other healthcare firm, however the place Baxter, above, markets to the skilled facet of that sector, CVS goals squarely on the client healthcare market. This firm is finest generally known as the CVS pharmacy chain, and is a staple of the retail scene. CVS shops provide a variety of house healthcare and hygiene merchandise, together with primary groceries, pharmacy companies, and a few extra specialised prescription medical gear. The corporate has introduced in additional than $130 billion in annual revenues for the previous three years.CVS’ revenues confirmed a slight dip this 12 months, throughout Q2, when financial circumstances deteriorated, however rapidly rebounded. The sequence of quarterly earnings in 2020, $66.7 billion, $65.Three billion, and $67.1 billion, present a gentle gross sales base, to be anticipated from a retailer dealing in merchandise primarily deemed important throughout the shutdown insurance policies. Q3 EPS got here in at $1.66, properly forward of consensus expectations of $1.33.The dividend right here is 50 cents per share, and has been held regular at that stage for over three years now. The cost annualizes to $2, and offers a yield of two.7%.Dalio’s Bridgewater purchased 320,039 shares of CVS inventory final quarter, increasing a take a look at place that the agency already held. The purchase boosted the full holding dramatically, to 333,804 shares, which are actually price $24.87 million.Deutsche Financial institution analyst George Hill notes that CVS seems to be set for a ‘peaceful transition of power’ when the present CEO, Larry Merlo, steps down subsequent 12 months. “Whereas we imagine Ms. Lynch will doubtless take into account executing upon CVS’ vertically built-in care supply technique, we do count on her to take a recent take a look at the enterprise and have little concern of exploring new instructions. We imagine Mr. Merlo’s legacy will likely be having the braveness to attempt to reshape and higher make the most of the struggling retail pharmacy with the Aetna deal,” Hill famous.”CVS is within the early innings on delivering in opposition to its imaginative and prescient of a vertically built-in healthcare companies firm with outsized client engagement,” the analyst concluded.To this finish, Hill charges CVS shares as a Purchase, and offers them a $101 worth goal, indicating his confidence in 35% development potential over the subsequent months. (To look at Hill’s monitor file, click on right here)Total, CVS has 7 current Purchase critiques and a pair of Holds, giving the inventory a Robust Purchase score from the analyst consensus. The typical worth goal is $83.29, suggesting an 11% upside from the present share worth of $74.50. (See CVS inventory evaluation on TipRanks)Darling Elements (DAR)With the final inventory, we transfer from healthcare to the meals trade. Darling Elements recycles the waste merchandise of the restaurant trade and the animal-processing trade – specifically, oils, fat, and grease – and manufactures usable meat and bone meals, yellow grease, and tallow. The corporate’s merchandise are utilized in pet meals, animal feeds, bioenergy, and fertilizers. Darling has delivered robust efficiency by way of 2020. The corporate’s quarterly earnings have held between $848 million and $852 million throughout the corona disaster, whereas earnings have been proven year-over-year good points in every quarter. The Q3 outcomes included 61 cents EPS on $850 million in high line revenues. DAR inventory has been rising steadily since final winter’s market crash, and is up ~77% year-to-date.That is one other new holding for Dalio and Bridgewater. Throughout Q3, the fund pulled the set off on 69,392 shares, which are actually price $3.46 million. Overlaying the inventory for Wolfe Analysis, 5-star analyst Sam Margolin is impressed by Darling’s mixture of cutting-edge renewable fuels and mature feed segments. “We rate DAR Outperform because of its rapid growth in the Renewable Diesel segment (Diamond Green Diesel JV), supported by its feedstock/manufacturing advantage sourced largely from the base business… DAR’s other segments are Food and Feed ingredients, which are relatively mature compared to Fuels. While we do not expect material growth in Food and Feed, we note that margins in the segments have been remarkably steady over recent years…”These feedback help Margolin’s Outperform (i.e. Purchase) score, and his $67 worth goal implies 34% upside development subsequent 12 months. (To look at Margolin’s monitor file, click on right here)Different analysts are on the identical web page. With 5 Buys and 1 Maintain acquired within the final three months, the phrase on the Avenue is that DAR is a Robust Purchase. Shares are presently priced at $49.87, and the $58.83 common worth goal suggests double-digit development of 18%. (See DAR inventory evaluation on TipRanks)To seek out good concepts for shares buying and selling at engaging valuations, go to TipRanks’ Greatest Shares to Purchase, a newly launched software that unites all of TipRanks’ fairness insights.Disclaimer: The opinions expressed on this article are solely these of the featured analysts. The content material is meant for use for informational functions solely. It is vitally vital to do your personal evaluation earlier than making any funding.